Aptevo Therapeutics Inc.APVONASDAQ

Revenue (LTM)

Net Income (LTM)

$-24M

-38.6% YoY

Free Cash Flow

$-24M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	4	12↑185.3%	3↓74.7%	0	0
Gross Profit	-14	12↑190.8%	3↓74.7%	0	-0
Operating Income	-27	-21↑22.2%	-29↓33.8%	-29↓0.8%	-25↑14.8%
Net Income	-18	-28↓60.3%	8↑128.2%	-17↓316.9%	-24↓38.6%
EBITDA	-26	-20↑22.7%	-28↓36.9%	-28↓2.1%	-24↑16.0%
EPS Diluted	-5546028.00	-3557646.00↑35.9%	921915.00↑125.9%	-834044.00↓190.5%	-31458.00↑96.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	40	45↑12.7%	23↓49.7%	17↓25.3%	9↓48.5%
Total Current Assets	47	53↑11.2%	27↓47.8%	19↓30.5%	11↓44.1%
Total Assets	54	57↑5.7%	34↓39.6%	25↓27.4%	16↓37.2%
Total Current Liabilities	15	35↑139.1%	9↓75.0%	7↓17.0%	6↓14.1%
Total Liabilities	37	55↑49.9%	16↓70.7%	13↓22.3%	11↓14.1%
Total Equity	17	1↓92.7%	18↑1378.1%	12↓32.0%	5↓61.1%
Total Debt	27	17↓39.0%	10↓43.0%	5↓43.4%	5↓14.2%
Net Debt	-13	-28↓125.5%	-13↑53.8%	-12↑12.2%	-4↑64.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-29	-22↑26.1%	-21↑3.0%	-12↑44.2%	-24↓102.8%
Capital Expenditure	-0	-1↓710.2%	-0↑95.9%	0	0
Free Cash Flow	-29	-22↑23.9%	-21↑6.0%	-12↑44.3%	-24↓102.8%
Stock-Based Comp	1	2↑30.9%	2↑9.7%	2↑21.7%	1↓51.3%
Net Change in Cash	23	4↓83.3%	-24↓727.9%	-6↑75.8%	-8↓42.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance